Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | RVTY | AVTR | ||
| Company | Charles River Laboratories Intl | Revvity Inc | Avantor Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 221.66 | 110.88 | 12.50 | ||
| High | 228.88 | 115.00 | 12.84 | ||
| Low | 215.00 | 105.70 | 12.09 | ||
| Latest | 218.99 | 110.14 | 12.60 | ||
| Change | +0.17 | +6.25 | +0.32 | ||
| % Change | +0.08% | +6.02% | +2.61% | ||
| Volume | 1,054,419 | 2,618,595 | 10,609,939 | ||
| 20-Day Average Volume | 665,836 | 1,185,840 | 10,433,662 | ||
| Previous Close | 218.82 | 103.89 | 12.28 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 205.77 | 99.66 | 11.63 | ||
| 20-Day Raw Stochastic | 73.26% | 75.15% | 87.53% | ||
| 20-Day Relative Strength | 71.14 | 66.16 | 60.97 | ||
| Weighted Alpha | +62.68 | +3.69 | -32.47 | ||
| Today's Opinion | 100% Buy | 88% Buy | 24% Sell | ||
| Previous Opinion | 100% Buy | 88% Buy | 40% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.33% since 01/06/26 | +4.85% since 01/06/26 | +2.69% since 01/06/26 | ||
| Low | 208.67 on 01/08/26 | 100.97 on 01/09/26 | 11.84 on 01/08/26 | ||
| High | 228.88 on 01/13/26 | 115.00 on 01/13/26 | 12.84 on 01/13/26 | ||
| 1-Month | |||||
| %Chg | +13.45% since 12/12/25 | +9.60% since 12/12/25 | +12.80% since 12/12/25 | ||
| Low | 191.89 on 12/19/25 | 95.44 on 12/16/25 | 10.91 on 12/17/25 | ||
| High | 228.88 on 01/13/26 | 115.00 on 01/13/26 | 12.84 on 01/13/26 | ||
| 3-Month | |||||
| %Chg | +28.33% since 10/13/25 | +21.06% since 10/13/25 | -8.56% since 10/13/25 | ||
| Low | 156.72 on 11/19/25 | 88.47 on 11/07/25 | 10.62 on 12/09/25 | ||
| High | 228.88 on 01/13/26 | 115.00 on 01/13/26 | 15.93 on 10/21/25 | ||
| 6-Month | |||||
| %Chg | +37.38% since 07/11/25 | +8.51% since 07/11/25 | -7.22% since 07/11/25 | ||
| Low | 144.26 on 09/25/25 | 81.36 on 09/04/25 | 10.62 on 12/09/25 | ||
| High | 228.88 on 01/13/26 | 115.00 on 01/13/26 | 15.93 on 10/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,769,226 | 11,778,631 | 8,372,688 | ||
| Shares Outstanding, K | 49,215 | 113,376 | 681,815 | ||
| Annual Sales | 4,049,990,000 | 2,755,030,000 | 6,783,600,000 | ||
| Annual Net Income | 22,200,000 | 270,390,000 | 711,500,000 | ||
| Last Quarter Sales | 1,004,850,000 | 698,950,000 | 1,623,800,000 | ||
| Last Quarter Net Income | 54,420,000 | 46,650,000 | -711,800,000 | ||
| 60-Month Beta | 1.61 | 1.05 | 0.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.43 on 11/05/25 | 1.18 on 10/27/25 | 0.22 on 10/29/25 | ||
| Latest Earnings Date | 02/18/26 | 01/30/26 | 02/06/26 | ||
| Most Recent Dividend | N/A | 0.070 on 10/17/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 01/16/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 20.94 | 21.80 | 12.93 | ||